NRO — Neurones SA Income Statement

0.000.00%

Last trade - 00:00

TechnologyBalancedMid CapHigh Flyer

Annual income statement for Neurones SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	524	580	665	741	810
Cost of Revenue
Gross Profit	524	579	665	740	810
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	473	518	592	665	732
Operating Profit	51.9	61.6	72.9	75.9	77.9
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	53.6	61.8	72.9	80.8	88.1
Provision for Income Taxes
Net Income After Taxes	35	42.9	51.8	58.6	63.2
Minority Interest
Net Income Before Extraordinary Items
Net Income	30.9	37.7	44.2	49.4	52.6
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	30.9	37.7	44.2	49.4	52.6
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.27	1.56	1.8	2	2.16
Dividends per Share